Skip to main content Skip to main navigation menu Skip to site footer

Clinical presentation of maternal death with COVID-19 in rural tertiary care center: A retrospective-descriptive Study

  • Devita Kurniawati ,
  • Budi Prasetyo ,
  • Hanindito Pandu ,
  • Arif Rahman Nurdianto ,

Abstract

Background: Maternal with to COVID-19 is a new maternal emergency issue leading to maternal morbidity and mortality. In Indonesia, the number of cases of maternal mortality with COVID-19 began to increase. This study aims to determine the characteristic of maternal deaths due to COVID-19 in a tertiary care center in Indonesia.

Method: This observational-retrospective study descriptively analyzed 15 maternal deaths due to COVID-19 admitted to the Department of Obstetrics and Gynaecology at the tertiary care teaching hospital from March to December 2020. We included suspect, probable, and confirmed COVID-19 in the samples. Therefore, the total sampling was recorded and analyzed descriptively by Microsoft Excel.

Results: There are fifteen maternal deaths from 429 maternal cases with COVID-19 in our hospital. The majority ages were in the age group 19-35 years (73.33%); body mass index (BMI) 25-29.9 (33.33%); five days average length of stay; one comorbidity (53.33%); and multiple comorbidities (20.00%). The case fatality rate (CFR) of maternal death due to COVID-19 is 3.49% were profiled out this study. The most cause of death was acute respiratory distress syndrome (ARDS) (53.33%).

Conclusions: Most common characteristics of the object of this study were the age between 19-35 years, comorbidity, obesity, upper respiratory tract symptoms, elevated D-dimer, and the complication of ARDS, which are the risk factors of the deaths.

References

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020/03/02. 2020;5(4):536–44. Available from: https://pubmed.ncbi.nlm.nih.gov/32123347
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020/01/24. 2020;395(10223):497–506. Available from: https://pubmed.ncbi.nlm.nih.gov/31986264
  3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020/02/26. 2020;109:102433. Available from: https://pubmed.ncbi.nlm.nih.gov/32113704
  4. Satuan Tugas Penanganan COVID-19. Peta Sebaran | Covid19.go.id [Internet]. 2020. Available from: https://covid19.go.id/peta-sebaran
  5. World Health Organization. Coronavirus Disease (COVID-19) Situation Reports [Internet]. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  6. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. lancet Gastroenterol Hepatol. 2020/03/20. 2020;5(6):529–30. Available from: https://pubmed.ncbi.nlm.nih.gov/32203680
  7. Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta. 2020/03/04. 2020;505:190–1. Available from: https://pubmed.ncbi.nlm.nih.gov/32145275
  8. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320–m3320. Available from: https://pubmed.ncbi.nlm.nih.gov/32873575
  9. Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet (London, England). 2020/02/05. 2020;395(10224):e35–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32035018
  10. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020/02/24. 2020;8(5):475–81. Available from: https://pubmed.ncbi.nlm.nih.gov/32105632
  11. Rees EM, Nightingale ES, Jafari Y, Waterlow N, Clifford S, Pearson CAB, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):1–22. Available from: http://dx.doi.org/10.1101/2020.04.30.20084780
  12. Kusnadi N, Respati SH, Sulistyowati S. Risk Factors of Maternal Death in Karanganyar, Central Java, Indonesia. J Matern Child Heal. 2019;4(6):499–506. Available from: http://dx.doi.org/10.26911/thejmch.2019.04.06.10
  13. Rohmah MK, Rahman Nurdianto A. Perspective of molecular immune response of SARS-COV-2 infection. J Teknol Lab. 2020;9(1):58–66. Available from: http://dx.doi.org/10.29238/teknolabjournal.v9i1.218
  14. Nurdianto AR, Nurdianto RF, Febiyanti DA. Infeksi COVID-19 pada kehamilan dengan insulin dependent diabetes mellitus (IDDM). J Ilm Kedokt Wijaya Kusuma. 2020;9(2):229. Available from: http://dx.doi.org/10.30742/jikw.v9i2.966
  15. Danese E, Montagnana M, Cervellin G, Lippi G. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence. Ann Med. 2014;46(6):364–71. Available from: http://dx.doi.org/10.3109/07853890.2014.912835
  16. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149–50. Available from: http://dx.doi.org/10.1038/d41573-020-00016-0

How to Cite

Kurniawati, D., Prasetyo, B., Pandu, H., & Nurdianto, A. R. (2022). Clinical presentation of maternal death with COVID-19 in rural tertiary care center: A retrospective-descriptive Study. Bali Medical Journal, 11(1), 87–90. https://doi.org/10.15562/bmj.v11i1.3158

HTML
0

Total
0

Share

Search Panel

Devita Kurniawati
Google Scholar
Pubmed
BMJ Journal


Budi Prasetyo
Google Scholar
Pubmed
BMJ Journal


Hanindito Pandu
Google Scholar
Pubmed
BMJ Journal


Arif Rahman Nurdianto
Google Scholar
Pubmed
BMJ Journal